Exhibitor's Profile
Scope Biosciences B.V. (Netherlands)
The scopeDx ® platform technology uses proprietary Type-III CRISPR-Cas nucleases to detect nucleic acid sequences, transforming our ability to detect genetic material on-site with ease, speed and incredible accuracy, for use in molecular diagnostics of infectious diseases, genotyping, and other applications. This makes the scopeDx ® platform the perfect solution for infectious disease detection in crop/cultivar-monitoring, adulteration detection and genotyping applications.
Exhibition Hall: Booth 9